{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Median duration of response and the confidence interval for the median duration will be computed.","groups":[{"description":"Patients receive temsirolimus IV over 30 minutes on days 1, 8, 15, and 22. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.\n\ntemsirolimus: Given IV","id":"OG000","title":"Treatment (Temsirolimus)"}],"populationDescription":"The study concluded terminated early and patients were not followed.","reportingStatus":"POSTED","timeFrame":"Up to 3 years","title":"Duration of Response, Defined for All Evaluable Patients Who Have Achieved an Objective Response as the Date at Which the Patient's Objective Status is First Noted to be Either a CR or PR to the Date Progression is Documented","type":"SECONDARY"}